Malignant Brain Tumors In Children Will Soon Be Able To Be Curable – Part 3 of 3
A aspect 2 trial in adults is already ongoing. “Preliminary analysis has shown benefits to these adult patients”. Because this was such an early trial, “we don’t yet know what impact this drug is successful to have on survival,” said Dr Lynn Schuchter, moderator of a news conference involving the trial and a professor of medicine at the Abramson Cancer Center at the University of Pennsylvania. “We don’t have a lot of material on follow-up, but this is really an amazing proof-of-principle idea and this pathway looks to be relevant in many cancers”. Schuchter reported ties to drug maker Pfizer Inc, while Gajjar reported no such ties.